James Harvard Pharma Re-brands to Hays Pharma

Following the recent acquisition of James Harvard Group by Hays PLC, James Harvard Pharma will be re-branded to become Hays Pharma, a specialist division within the Hays Group. The new division combines the expertise of James Harvard Pharma as Europe’s market leader in clinical research staffing, with the worldwide infrastructure and coverage of Hays Specialist Recruitment – the sixth largest recruitment consultancy in the world.

Over the last five years since foundation, James Harvard Pharma has built a leading reputation for delivering staff in the clinical research and drug approval functions across the UK and Europe. However, the opportunity to become part of the multinational Hays Group has created the opportunity to expand the business on a truly global scale. By utilising the Hays office network that spans 350 offices in 25 countries with 6,500 employees, James Harvard Pharma will be able to replicate its business model across 20 different countries.

Paul Strouts, UK Managing Director of Hays Pharma, comments: “The re-brand to Hays Pharma provides increased opportunities for professionals working within the pharmaceutical and biotech industries in permanent and freelance employment. Jobseekers and employers can enjoy the enhanced geographic presence and the added benefit of working with the only truly global specialist pharmaceutical consultancy.”

For further information visit www.hayspharma.com

Note to Editor

About Hays: Hays, a FTSE-250 company, is the sixth-largest recruitment business in the world. Hays has specialist recruitment operations in a number of different sectors and employs over 6,000 employees in the UK, Ireland, continental Europe, the Middle East, Asia, South America, Australia, New Zealand and Canada.

For further press information contact:
Samantha Bell
Senior Marketing Manager, Hays
e: samantha.bell@hays.com  
t: 020 7222 8575

June, 2007